Printer Friendly

DU PONT MERCK ANNOUNCES PERSONNEL APPOINTMENT

 WILMINGTON, Del., April 22 /PRNewswire/ -- The Du Pont Merck Pharmaceutical Company has appointed Robert W. Perkins, of Wilmington, as Director of Public Affairs. He will be responsible for worldwide public affairs including media relations, issues management, community relations and company contributions. He will report to Thomas J. Bucknum, senior vice president and general counsel.
 /EDITORS: NO-CHARGE DIAL-UP LOGO ACCOMPANIES THIS STORY/
 (Instructions below)
 Before joining Du Pont Merck, Perkins was chief operating officer for Richards, Layton and Finger, Delaware's largest law firm. Prior to that, he was deputy campaign manager and communications director for the Pete du Pont for President Campaign and previously served as Chief of Staff for Michael N. Castle, former governor of Delaware. Prior to his appointment in the Governor's office, Perkins worked in public affairs in the chemical industry, at Du Pont, and in the nuclear industry, at Babcock & Wilcox Canada, Ltd. Perkins earned a B.A. in English Literature from Lynchburg College. Married and the father of three children, he serves on the Corporate Council Marketing Committee for the Winterthur Museum.
 Du Pont Merck is a Fortune 500, research-based pharmaceutical company focusing on the discovery, development and delivery of important pharmaceuticals to treat unmet medical needs primarily in the fight against heart disease, cancer, arthritis, Alzheimer's Disease and AIDS. The company is a partnership of DuPont (NYSE: DD) and Merck and Co., Inc., (NYSE: MRK) headquartered in Wilmington, with more than 5,000 employees worldwide.
 -0- 4/22/93
 /Editors: Du Pont Merck's corporate logo is available without charge on your photo receiver. Have photo editor dial in to 212-967-1293, 212-643-2005 or 212-643-2006 for PRN060192PH1B./
 /CONTACT: Maureen A. Maloney of Du Pont Merck Pharmaceutical, 302-892-8236/
 (DD MRK)


CO: Du Pont Merck Pharmaceutical Company ST: Delaware IN: MTC SU: PER

MJ -- PH015 -- 9388 04/22/93 11:38 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 22, 1993
Words:303
Previous Article:NEW YORK LIFE FILES A $300 MILLION DEBENTURE OFFERING
Next Article:MEDIC COMPUTER SYSTEMS ANNOUNCES FIRST QUARTER 1993 FINANCIAL RESULTS
Topics:


Related Articles
DU PONT MERCK NAMES ARNER ASSISTANT GENERAL COUNSEL
DU PONT MERCK NAMES HORNER MANAGING DIRECTOR FOR U.K.
DU PONT MERCK CEO RECEIVES HONORARY DOCTORATE
DU PONT MERCK NAMES FLETCHER AS GOVERNMENT AFFAIRS MANAGER
DU PONT MERCK NAMES BLANK VP FOR WORLDWIDE MARKETING
DU PONT MERCK HONORS OUTSTANDING SALES ACHIEVEMENTS: DISTRICT OF THE YEAR AWARDS
ANTONIO J. GRILLO-LOPEZ JOINS IDEC PHARMACEUTICALS AS VICE PRESIDENT, MEDICAL AND REGULATORY AFFAIRS
ANTONIO J. GRILLO-LOPEZ JOINS IDEC PHARMACEUTICALS AS VICE PRESIDENT, MEDICAL AND REGULATORY AFFAIRS
MEDCO RESEARCH NAMES DIRECTOR, RADIOPHARMACEUTICAL CLINICAL RESEARCH
DU PONT MERCK EXECUTIVE JOINS SYMPHONY PHARMACEUTICALS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters